[Mannitol. II. Evaluation of its use on the kidney in shock].
D058186:Acute Kidney Injury / Q000209:etiology / Q000517:prevention & control*; D000818:Animals; D001002:Anuria / Q000150:complications / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology; D002056:Burns / Q000150:complications; D004231:Diuresis; D005919:Glomerular Filtration Rate; D006801:Humans; D007511:Ischemia / Q000150:complications / Q000209:etiology / Q000503:physiopathology; D007668:Kidney / Q000187:drug effects; D008353:Mannitol / Q000008:administration & dosage / Q000627:therapeutic use*; D009336:Necrosis; D011817:Rabbits; D012039:Regional Blood Flow; D012771:Shock, Hemorrhagic / Q000150:complications; D012773:Shock, Surgical / Q000150:complications; D012774:Shock, Traumatic / Q000150:complications
D008353:Mannitol
Le mannitol. II. Evaluation de son emploi dans le rein du choc.